Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innovex International (INVX) Current Deferred Revenue (2017 - 2025)

Innovex International (INVX) has disclosed Current Deferred Revenue for 9 consecutive years, with $10.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Current Deferred Revenue fell 27.0% year-over-year to $10.3 million, compared with a TTM value of $10.3 million through Sep 2025, down 27.0%, and an annual FY2024 reading of $13.5 million, changed N/A over the prior year.
  • Current Deferred Revenue was $10.3 million for Q3 2025 at Innovex International, up from $6.9 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $14.1 million in Q3 2024 and bottomed at $5.6 million in Q3 2021.
  • Average Current Deferred Revenue over 5 years is $9.2 million, with a median of $8.1 million recorded in 2022.
  • The sharpest move saw Current Deferred Revenue surged 115.49% in 2021, then plummeted 53.07% in 2022.
  • Year by year, Current Deferred Revenue stood at $9.7 million in 2021, then fell by 17.71% to $8.0 million in 2022, then increased by 0.97% to $8.1 million in 2023, then soared by 66.25% to $13.5 million in 2024, then dropped by 23.6% to $10.3 million in 2025.
  • Business Quant data shows Current Deferred Revenue for INVX at $10.3 million in Q3 2025, $6.9 million in Q2 2025, and $11.1 million in Q1 2025.